Literature DB >> 32804352

Melatonin 1A and 1B Receptors' Expression Decreases in the Placenta of Women with Fetal Growth Restriction.

Andrii M Berbets1, Igor S Davydenko2, Adrian M Barbe2, Dmytro H Konkov3, Olena M Albota2, Oleksandr M Yuzko2.   

Abstract

Melatonin and its metabolites prevent oxidative stress and apoptosis, and it is actively produced by the placenta during pregnancy. Melatonin 1A and 1B receptors are present in human villous trophoblastic cells. We aimed to investigate the expression of melatonin 1A and 1B receptors in human placental tissue in the case of placental insufficiency manifested as the intrauterine growth restriction syndrome of the fetus (IUGR). Thirty-two pregnant women aged 18-36 with placental insufficiency manifested at the term 36 weeks of gestation as the IUGR syndrome (the estimated fetal weight less than the 3rd percentile) were included in the experimental group; all their babies had the diagnosis confirmed at birth, which occurred after 37 weeks of gestation. The control group consisted of 30 women with uncomplicated pregnancy of the same term. Pieces of the placental tissue were obtained after deliveries, and melatonin 1A and 1B receptors were immunoassayed; the richness of melatonin receptors in the placental tissue was estimated on the basis of immunohistochemical (IHC) staining of receptors, calculated in the IHC image score. The optical density of melatonin 1A receptors in the placentas obtained from women whose pregnancies were complicated with IUGR was significantly lower than that in the placentas from uncomplicated pregnancies: generally in the trophoblast, it was 0.095 ± 0.0009 IHC image score (in the control group, 0.194 ± 0.0015, p < 0.0001); in the apical parts of the syncytiotrophoblast, 0.108 ± 0.0016 IHC image score (in the control group, 0.221 ± 0.0013, p < 0.0001); and in the stromal cells of placental villi, 0.112 ± 0.0013 IHC image score (in the control group, 0.156 ± 0.0011, p < 0.0001). The optical density of melatonin 1B receptors in placentas obtained from women whose pregnancies were complicated with IUGR was also lower than that in the placentas from uncomplicated pregnancies: generally in the trophoblast, it was 0.165 ± 0.0019 IHC image score (in the control group, 0.231 ± 0.0013, p < 0.0001), and in the apical parts of the syncytiotrophoblast, 0.188 ± 0.0028 IHC image score (in the control group, 0.252 ± 0.0009, p < 0.0001). There was no difference found in the optical density of melatonin 1B receptors in the stromal cells of placental villi between the two groups: in the experimental group, 0.109 ± 0.006 IHC image score, and in the control group, 0.114 ± 0.0011 (p = 0.65). Melatonin receptors 1A and 1B are significantly less expressed in the placental tissue in the case that pregnancy is complicated with placental insufficiency, manifested as the intrauterine growth restriction syndrome of the fetus.

Entities:  

Keywords:  IUGR; Melatonin; Melatonin 1A receptors; Melatonin 1B receptors; Placenta

Year:  2020        PMID: 32804352     DOI: 10.1007/s43032-020-00285-5

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  48 in total

1.  Pineal gland (melatonin) affects the parturition time, but not luteal function and fetal growth, in pregnant rats.

Authors:  Hisako Takayama; Yasuhiko Nakamura; Hiroshi Tamura; Yoshiaki Yamagata; Ayako Harada; Masahiko Nakata; Norihiro Sugino; Hiroshi Kato
Journal:  Endocr J       Date:  2003-02       Impact factor: 2.349

Review 2.  The endocrine function of human placenta: an overview.

Authors:  Mariana A Costa
Journal:  Reprod Biomed Online       Date:  2015-10-27       Impact factor: 3.828

3.  Placental melatonin system is present throughout pregnancy and regulates villous trophoblast differentiation.

Authors:  Ahmed Soliman; Andrée-Anne Lacasse; Dave Lanoix; Lucas Sagrillo-Fagundes; Véronique Boulard; Cathy Vaillancourt
Journal:  J Pineal Res       Date:  2015-04-20       Impact factor: 13.007

4.  Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations.

Authors:  Carmen Venegas; José A García; Germaine Escames; Francisco Ortiz; Ana López; Carolina Doerrier; Laura García-Corzo; Luis C López; Russel J Reiter; Darío Acuña-Castroviejo
Journal:  J Pineal Res       Date:  2011-09-02       Impact factor: 13.007

5.  Steroid hormones and pregnancy.

Authors:  Nancy Noyola-Martínez; Ali Halhali; David Barrera
Journal:  Gynecol Endocrinol       Date:  2019-02-22       Impact factor: 2.260

6.  Human placental trophoblasts synthesize melatonin and express its receptors.

Authors:  Dave Lanoix; Hamza Beghdadi; Julie Lafond; Cathy Vaillancourt
Journal:  J Pineal Res       Date:  2008-02-25       Impact factor: 13.007

Review 7.  Melatonin and stable circadian rhythms optimize maternal, placental and fetal physiology.

Authors:  Russel J Reiter; Dun Xian Tan; Ahmet Korkmaz; Sergio A Rosales-Corral
Journal:  Hum Reprod Update       Date:  2013-10-16       Impact factor: 15.610

8.  The Human Placenta Project: placental structure, development, and function in real time.

Authors:  A E Guttmacher; Y T Maddox; C Y Spong
Journal:  Placenta       Date:  2014-03-06       Impact factor: 3.481

9.  Melatonin improves placental efficiency and birth weight and increases the placental expression of antioxidant enzymes in undernourished pregnancy.

Authors:  Hans G Richter; Jeremy A Hansell; Shruti Raut; Dino A Giussani
Journal:  J Pineal Res       Date:  2009-03-25       Impact factor: 13.007

10.  Melatonin improves the efficiency of super-ovulation and timed artificial insemination in sheep.

Authors:  Yukun Song; Hao Wu; Xuguang Wang; Aerman Haire; Xiaosheng Zhang; Jinlong Zhang; Yingjie Wu; Zhengxing Lian; Juncai Fu; Guoshi Liu; Abulizi Wusiman
Journal:  PeerJ       Date:  2019-04-25       Impact factor: 2.984

View more
  5 in total

Review 1.  Effects of Antioxidant Intake on Fetal Development and Maternal/Neonatal Health during Pregnancy.

Authors:  Giorgia Sebastiani; Elisabet Navarro-Tapia; Laura Almeida-Toledano; Mariona Serra-Delgado; Anna Lucia Paltrinieri; Óscar García-Algar; Vicente Andreu-Fernández
Journal:  Antioxidants (Basel)       Date:  2022-03-28

2.  Docosahexaenoic Acid and Melatonin Prevent Impaired Oligodendrogenesis Induced by Intrauterine Growth Restriction (IUGR).

Authors:  Britta Anna Kühne; Paula Vázquez-Aristizabal; Mercè Fuentes-Amell; Laura Pla; Carla Loreiro; Jesús Gómez-Catalán; Eduard Gratacós; Miriam Illa; Marta Barenys
Journal:  Biomedicines       Date:  2022-05-23

Review 3.  Is Melatonin the "Next Vitamin D"?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements.

Authors:  Deanna M Minich; Melanie Henning; Catherine Darley; Mona Fahoum; Corey B Schuler; James Frame
Journal:  Nutrients       Date:  2022-09-22       Impact factor: 6.706

4.  Melatonin Type 2 Receptor Activation Regulates Blue Light Exposure-Induced Mouse Corneal Epithelial Damage by Modulating Impaired Autophagy and Apoptosis.

Authors:  Rujun Jin; Ying Li; Hui Jin; Hee Su Yoon; Ji Suk Choi; Jonghwa Kim; Hyeon Jeong Yoon; Kyung Chul Yoon
Journal:  Int J Mol Sci       Date:  2022-09-26       Impact factor: 6.208

Review 5.  Hypoxia and Mitochondrial Dysfunction in Pregnancy Complications.

Authors:  Xiang-Qun Hu; Lubo Zhang
Journal:  Antioxidants (Basel)       Date:  2021-03-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.